Vale SA
VALE
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
Lennar Corp
LEN
KB Home
KBH
US Stock MarketDetailed Quotes
DSGN Design Therapeutics
- 4.200
- +0.010+0.24%
Trading Mar 28 13:35 ET
238.40MMarket Cap-4.77P/E (TTM)
4.280High4.100Low9.90KVolume4.190Open4.190Pre Close41.60KTurnover0.04%Turnover RatioLossP/E (Static)56.76MShares7.77052wk High0.98P/B106.60MFloat Cap3.15052wk Low--Dividend TTM25.38MShs Float50.500Historical High--Div YieldTTM4.30%Amplitude1.940Historical Low4.204Avg Price1Lot Size
About Design Therapeutics Company
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Company Profile
SymbolDSGN
Company NameDesign Therapeutics
Listing DateMar 26, 2021
Issue Price20.00
Founded2017
CEODr. Pratik Shah, PhD
MarketNASDAQ
Employees54
Fiscal Year Ends12-31
Address6005 Hidden Valley Road,Suite 110
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92011
Phone1-858-293-4900
Websitehttp://www.designtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Pratik Shah, PhD
- Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer
- 6.32M
- Dr. Sean Jeffries, PhD
- Chief Operating Officer
- 1.28M
- Dr. Jae B. Kim, M.D.
- Chief Medical Officer
- --
- Julie Burgess
- Chief Accounting Officer
- --
- Deepa Prasad
- Independent Director
- 94.20K
- John P. Schmid
- Independent Director
- 106.70K
- Dr. Simeon J. George, M.B.A.,M.D.
- Lead Independent Director
- 95.70K
- Dr. Rodney W. Lappe, PhD
- Independent Director
- 228.56K
- Dr. Heather Berger, PhD
- Independent Director
- 94.20K
- Dr. Arsani William, M.D.
- Independent Director
- 104.20K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.